{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:35:33Z","timestamp":1788010533127,"version":"build-2784847793"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw\/University of Warsaw","doi-asserted-by":"publisher","award":["FW24\/NUW1\/19"],"award-info":[{"award-number":["FW24\/NUW1\/19"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsps.2019.11.025","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T02:28:51Z","timestamp":1575685731000},"page":"220-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Coumarin-piperazine derivatives as biologically active compounds"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-646X","authenticated-orcid":false,"given":"Kinga","family":"Ostrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2019.11.025_b0005","first-page":"223","article-title":"Hymecromone in the treatment of motor disorders of the bile ducts: a multicenter, double-blind, placebo-controlled clinical study","volume":"27","author":"Abate","year":"2001","journal-title":"Drugs. Exp. Clin. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(94)12127-C","article-title":"Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides","volume":"201","author":"Alvarez","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"Review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"Suppl 3","key":"10.1016\/j.jsps.2019.11.025_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-3083.2012.04519.x","article-title":"Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jsps.2019.11.025_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.acc.2019.01.005","article-title":"Advances in monitoring anticoagulant therapy","volume":"90","author":"Bo\u017ei\u010d-Mijovski","year":"2019","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0030","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2174\/1381612043383421","article-title":"Recent approaches to novel anti-Alzheimer therapy","volume":"10","author":"Carreiras","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jsps.2019.11.025_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00034983.1993.11812763","article-title":"Reduction of filaritic lymphoedema and elephantiasis by 5,6-benzo-5-pyrone(coumarin), and the effect of diethylcarbamazine (DEC)","volume":"87","author":"Casley-Smith","year":"1993","journal-title":"Ann. Trop. Med. Parasit."},{"key":"10.1016\/j.jsps.2019.11.025_b0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejphar.2010.06.043","article-title":"Antidepressant-like effect ofscopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) inmice: evidence for the involvement of monoaminergic systems","volume":"643","author":"Capra","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jsps.2019.11.025_b0045","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/jm400408r","article-title":"Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics","volume":"56","author":"Chen","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejmech.2014.01.012","article-title":"Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics","volume":"74","author":"Chen","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ddstr.2004.08.015","article-title":"Recent advances in the treatment of gram-positive infections","volume":"1","author":"Coleman","year":"2004","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.jsps.2019.11.025_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/genes10040261","article-title":"Pharmacogenetics in the treatment of cardiovascular diseases and its current progres regarding implementation in the clinical routine","volume":"10","author":"D\u00e1vila-Fajardo","year":"2019","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.jsps.2019.11.025_b0065","first-page":"150","article-title":"The pharmacodynamic characterization of coumarin","author":"Ellinger","year":"1908","journal-title":"Arch. Exp. Pathol. Phar. Supplement"},{"key":"10.1016\/j.jsps.2019.11.025_b0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ardp.200700090","article-title":"Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety","volume":"341","author":"Emami","year":"2008","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.jsps.2019.11.025_b0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00034983.1992.11812684","article-title":"Diethylcarbamazine treatment of bancroftian and Malayan filariasis with emphasis on side effects","volume":"86","author":"Fan","year":"1992","journal-title":"Ann. Trop. Med. Parasit."},{"key":"10.1016\/j.jsps.2019.11.025_b0080","doi-asserted-by":"crossref","first-page":"100395","DOI":"10.1371\/journal.pone.0100395","article-title":"Identification of licopyranocoumarin and glycyrurol from herbal medicinesas neuroprotective compounds for Parkinson\u2019s disease","volume":"9","author":"Fujimaki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jsps.2019.11.025_b0085","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bmcl.2005.12.064","article-title":"BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline","volume":"16","author":"Garino","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0090","unstructured":"Gierlak, W., Kuch, M., 2010. How to use cardiac drugs in everyday practice? In: Czelej, D\u0142u\u017cniewski, M., (Eds.), Anticoagulants in cardiology - Vitamin K antagonists. chapter 6."},{"key":"10.1016\/j.jsps.2019.11.025_b0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-894X(02)00933-2","volume":"13","author":"Gonzalez-Gomez","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejmech.2015.03.051","article-title":"Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents","volume":"95","author":"Hua","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0105","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/1871520616666160926113109","article-title":"4-Methylumbelliferones analogues as anticancer agents: synthesis and in cell pharmacological studies","volume":"17","author":"Huang","year":"2017","journal-title":"Anti-Cancer Agents Me."},{"key":"10.1016\/j.jsps.2019.11.025_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1527-3458.2002.tb00220.x","article-title":"Ensaculin (KA-672HCl): a multitransmitter approachto dementia treatment","volume":"8","author":"Hoerr","year":"2002","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jsps.2019.11.025_b0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0306-3623(95)02112-4","article-title":"Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential","volume":"27","author":"Hoult","year":"1996","journal-title":"Gen. Pharmacol. Vasc. S."},{"key":"10.1016\/j.jsps.2019.11.025_b0125","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1039\/C8PP00011E","article-title":"Drug and chemical induced photosensitivity from a clinical perspective","volume":"5","author":"Ibbotson","year":"2018","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jsps.2019.11.025_b0130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1248\/yakushi1947.71.7_686","article-title":"Research on coumarin derivatives for medicinal purpose. 3. Sedative and hypnotic actions","volume":"71","author":"Ito","year":"1951","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jsps.2019.11.025_b0135","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1248\/yakushi1947.71.6_596","article-title":"Research on coumarin derivatives for medicinal purpose. 2. The toxicity of coumarin, 2-thiocoumarin ans 4-methylcoumarin","volume":"71","author":"Ito","year":"1951","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jsps.2019.11.025_b0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1248\/yakushi1947.70.12_730","article-title":"Coumarin derivatives for medical purpose.1. Anthelmintic action","volume":"70","author":"Ito","year":"1950","journal-title":"Yakugaku Zasshi."},{"key":"10.1016\/j.jsps.2019.11.025_b0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","article-title":"Dopamine receptors and brain function","volume":"35","author":"Jaber","year":"1996","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jsps.2019.11.025_b0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/znc-1999-3-405","article-title":"Antibacterial activity of simple coumarins: structural requirements for biological activity","volume":"54","author":"Kayser","year":"1999","journal-title":"Z. Naturforsch. C."},{"key":"10.1016\/j.jsps.2019.11.025_b0155","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2174\/092986706778521968","article-title":"Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents","volume":"13","author":"Kulkarni","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570180811666141009234835","article-title":"The Novel derivatives of 3-(iminomethyl)-2H-chromen-2-one with thiourea and piperazine structural motive: rationale, synthesis, antimicrobialand anti-TB evaluation","volume":"12","author":"Lakum","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.jsps.2019.11.025_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02980046","article-title":"Acetylcholinesteraseinhibitors from the twigs of Vaccinium oldhami Miquel","volume":"27","author":"Lee","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/jm901652p","article-title":"Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice","volume":"53","author":"Li","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0175","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/092986708784310422","article-title":"Natural products and theirderivatives as cholinesterase inhibitors in the treatment ofneurodegenerative disorders: an update","volume":"15","author":"Loizzo","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0180","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1007\/s00044-013-0543-2","article-title":"Synthesis, antimicrobial activity, and molecular modeling of novel 4-(3-(4-benzyl piperazin-1-yl)propoxy)-7-methoxy-3-substituted phenyl-2H-chromen-2-one","volume":"22","author":"Mandala","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1090-0233(05)80005-X","article-title":"Modes of action of anthelmintic drugs","volume":"154","author":"Martin","year":"1997","journal-title":"Vet. J."},{"key":"10.1016\/j.jsps.2019.11.025_b0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2958.1993.tb01728.x","article-title":"The interaction between coumarin drugs and DNA gyrase","volume":"9","author":"Maxwell","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jsps.2019.11.025_b0195","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ardp.201300242","article-title":"Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors","volume":"346","author":"Modh","year":"2013","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.jsps.2019.11.025_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/znc-2008-1-205","article-title":"Antifungal activity of coumarins","volume":"63","author":"Montagner","year":"2008","journal-title":"Z. Naturforsch. C."},{"key":"10.1016\/j.jsps.2019.11.025_b0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1440-1789.2000.00317.x","article-title":"Untangling Alzheimer's disease from fibrous lesions of neurofibrillary tangles and senile plaques","volume":"20","author":"Mori","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.jsps.2019.11.025_b0210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0960-894X(00)00304-8","article-title":"Improved antibacterial activities of coumarin antibiotics bearing 50,50-dialkylnoviose: biological activity of RU79115","volume":"10","author":"Musicki","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0215","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/molecules16054305","article-title":"Synthesis, and antitumor activity of some N1-(coumarin-7-yl) amidrazones and aelated congeners","volume":"16","author":"Mustafa","year":"2011","journal-title":"Molecules."},{"key":"10.1016\/j.jsps.2019.11.025_b0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2174\/1570180814666170322154750","article-title":"Ultrasound assisted-synthesis and biological evaluation of piperazinylprop-1-en-2-yloxy-2H-chromen-2-ones as cytotoxic agents","volume":"14","author":"Nikalje","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.jsps.2019.11.025_b0225","doi-asserted-by":"crossref","unstructured":"Opherk, D., Schuler, G., Waas, W., Dietz, R., Kubler, W., 1990. Intravenous carbochromen: a potent and effective drug for estimation of coronary dilatory capacity. 11, 342\u2013347. DOI: 10.1093\/oxfordjournals.eurheartj.a059708.","DOI":"10.1093\/oxfordjournals.eurheartj.a059708"},{"key":"10.1016\/j.jsps.2019.11.025_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1515\/znc-2008-5-610","article-title":"Coumarin, anthraquinone and stilbenederivatives with anticholinesterase activity","volume":"63","author":"Orhan","year":"2008","journal-title":"Z. Naturforsch. C."},{"key":"10.1016\/j.jsps.2019.11.025_b0235","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1039\/C7MD00281E","article-title":"Development of selective agents targeting serotonin 5HT1A receptors with subnanomolar activities based on a coumarin core","volume":"8","author":"Ostrowska","year":"2017","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.jsps.2019.11.025_b0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2017.05.047","article-title":"Synthesis of a new series of aryl\/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT1A affinities","volume":"137","author":"Ostrowska","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bmc.2017.12.016","article-title":"5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives","volume":"26","author":"Ostrowska","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0250","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis. B","volume":"75","author":"Ottesen","year":"1997","journal-title":"World Health Organ."},{"key":"10.1016\/j.jsps.2019.11.025_b0255","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s00044-011-9822-y","article-title":"Synthesis of 3-{4-[4-dimethylamino-6-(4-methyl-2-oxo-2Hchromen-7-yloxy)-[1,3,5]triazin-2-ylamino]-phenyl}-2-phenyl-5-(4-pyridin-2-yl-piperazin-1-ylmethyl)-thiazolidin-4-one and their biological evaluation","volume":"21","author":"Patel","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0260","first-page":"879","article-title":"Microwave-assisted synthesis of coumarin based 1,3,5-triazinyl piperazines and piperidines and their antimicrobial activities","volume":"69","author":"Patel","year":"2012","journal-title":"Acta Polon. Pharm. Drug Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0265","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00044-011-9676-3","article-title":"In vitro antimicrobial assessment of coumarin-based s-triazinyl piperazines","volume":"21","author":"Patel","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0270","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.03.021","article-title":"Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors","volume":"64","author":"Razavi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0275","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1021\/jm049655r","article-title":"Acetylcholinesterase inhibitory activity of scopolin and scopoletindiscovered by virtual screening of natural products","volume":"47","author":"Rollinger","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2016.08.006","article-title":"Pharmacological treatments of cardiovascular diseases: evidence from real-life studies","volume":"118","author":"Salvo","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0285","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0223-5234(02)01357-0","volume":"37","author":"Santana","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0290","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0960-894X(01)00257-8","article-title":"Fine tuning of physico-chemical parameters to optimise a new series of novobiocin analogues","volume":"11","author":"Schio","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genom.3.022502.103022","article-title":"Deciphering the genetic basis of Alzheimer's disease","volume":"3","author":"Selkoe","year":"2002","journal-title":"Annu. Rev. Genom. Hum. G."},{"key":"10.1016\/j.jsps.2019.11.025_b0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.9758\/cpn.2014.12.3.196","article-title":"Serotonin and mental disorders: a concise review on molecular neuroimaging evidence","volume":"12","author":"Shih-Hsien","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jsps.2019.11.025_b0305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cber.19000330159","article-title":"Tribromine coumarin and some of its derivetives","volume":"33","author":"Simonis","year":"1900","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.jsps.2019.11.025_b0310","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.phrs.2015.11.023","article-title":"Implication of coumarins towards central nervous system disorders","volume":"103","author":"Skalicka-Wozniak","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2013.04.015","article-title":"Coumarin derivatives protect against ischemic brain injury in rats","volume":"67","author":"Sun","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0320","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/S0960-894X(98)00646-5","article-title":"Phenylpiperazine derivatives with strong affinity for 5-HT1A, D2A and D3 receptors","volume":"8","author":"Teran","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsps.2019.11.025_b0325","unstructured":"Tripathi, R.P., Khan, A.R., Singh, S.N., Murthy, P.K., Chatterjee, R.K., Bhaduri, A.P., 1997.A process for the preparation of 4-alkyl-7-0 [N,N-di(mono)substituted acetamide-2-yl-2H -1-benzopyran-2-ones useful as filaricidal agent. Indian Patent Application. No. 1265\/DEL\/97\/13\/05\/97."},{"key":"10.1016\/j.jsps.2019.11.025_b0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0001-706X(03)00066-4","article-title":"7-O-[4-methyl piperazine-1-(2-acetyl)]-2H-1-benzopyran-2-one: a novel antifilarial lead compound","volume":"87","author":"Tripathi","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.jsps.2019.11.025_b0335","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ejmech.2011.03.006","article-title":"Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin","volume":"46","author":"Trykowska Konc","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0340","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmc.2014.09.048","article-title":"Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0345","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00023210-199912040-00005","article-title":"Selectivity of cholinesterase inhibition","volume":"12","author":"Weinstock","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jsps.2019.11.025_b0350","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.31.1109","article-title":"Antidepressant-like effects of psoralen isolated from theseeds of Psoralea corylifolia in the mouse forced swimming test","volume":"31","author":"Xu","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsps.2019.11.025_b0355","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bioorg.2016.07.013","article-title":"Design, synthesis and biological evaluation of coumarin derivatives as novel acetylcholinesterase inhibitors that attenuate H2O2-induced apoptosis in SH-SY5Y cells","volume":"68","author":"Yao","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0360","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jnr.22009","article-title":"Effects of scoparone on dopamine biosynthesis and L-DOPA-inducedcytotoxicity in PC12 cells","volume":"87","author":"Yang","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0365","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00044-018-2185-x","article-title":"Synthesis and evaluation of coumarin\/piperazine hybrids as acetylcholinesterase inhibitors","volume":"27","author":"Zhang","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jsps.2019.11.025_b0370","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bioorg.2018.11.034","article-title":"Evaluation of blood-brain barrier penetration and examination of binding to human serum albumin of 7-O-arylpiperazinylcoumarins as potential antipsychotic agents","volume":"84","author":"\u017bo\u0142ek","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jsps.2019.11.025_b0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2018.01.011","article-title":"Drug likeness prediction of 5-hydroxy-substituted coumarins with high affinity to 5-HT1A and 5-HT2A receptors","volume":"115","author":"\u017bo\u0142ek","year":"2018","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016419301677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016419301677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:24:08Z","timestamp":1736184248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016419301677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1319016419301677"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2019.11.025","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin-piperazine derivatives as biologically active compounds","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2019.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}